253
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults

, , , &
Pages 663-669 | Received 12 Feb 2016, Accepted 02 May 2016, Published online: 20 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Masako Mizusawa & Karen C Carroll. (2021) Advances and required improvements in methods to diagnosing Clostridioides difficile infections in the healthcare setting. Expert Review of Molecular Diagnostics 21:3, pages 311-321.
Read now
Yao-Wen Cheng & Monika Fischer. (2020) Clinical management of severe, fulminant, and refractory Clostridioides difficile infection. Expert Review of Anti-infective Therapy 18:4, pages 323-333.
Read now
Joseph P. Zackular & Eric P. Skaar. (2018) The role of zinc and nutritional immunity in Clostridium difficile infection. Gut Microbes 9:5, pages 469-476.
Read now
Antonella Gallo, Carla Vallone, Ludovico Sabatelli, Giulio Ventura, Marcello Covino, Giovanni Cammarota, Antonio Gasbarrini, Raffaele Landolfi & Massimo Montalto. (2018) Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study. Scandinavian Journal of Gastroenterology 53:5, pages 567-572.
Read now

Articles from other publishers (15)

Bao-Jiang Wen, Li-Ger Te, Xiao-Xuan Liu & Jian-Hong Zhao. (2022) The value of fecal calprotectin in Clostridioides difficile infection: A systematic review. Frontiers in Physiology 13.
Crossref
Travis J. Carlson, Anne J. Gonzales-Luna & Kevin W. Garey. (2022) Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection. Seminars in Respiratory and Critical Care Medicine 43:01, pages 028-038.
Crossref
Masako Mizusawa & Karen C. Carroll. (2021) The future of Clostridioides difficile diagnostics. Current Opinion in Infectious Diseases Publish Ahead of Print.
Crossref
Colleen R. KellyMonika FischerJessica R. AllegrettiKerry LaPlanteDavid B. StewartBerkeley N. LimketkaiNeil H. Stollman. (2021) ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. American Journal of Gastroenterology 116:6, pages 1124-1147.
Crossref
Makan Golizeh, Kaitlin Winter, Lucie Roussel, Marija Landekic, Mélanie Langelier, Vivian G. Loo, Momar Ndao & Donald C. Vinh. (2021) Fecal host biomarkers predicting severity of Clostridioides difficile infection. JCI Insight 6:1.
Crossref
Valencia Ru Yan Zhang, Aaron Shu Jeng Woo, Christina Scaduto, Maria Teresa Kasunuran Cruz, Yan Yuan Tan, Hao Du, Mengling Feng & Kewin Tien Ho Siah. (2020) Systematic review on the definition and predictors of severe Clostridiodes difficile infection . Journal of Gastroenterology and Hepatology 36:1, pages 89-104.
Crossref
Joseph P. Zackular, Reece J. Knippel, Christopher A. Lopez, William N. Beavers, C. Noel Maxwell, Walter J. Chazin & Eric P. Skaar. (2020) ZupT Facilitates Clostridioides difficile Resistance to Host-Mediated Nutritional Immunity. mSphere 5:2.
Crossref
Joowon YiHanah KimHee-Won Moon, Mina HurYeo-Min Yun. (2020) Clinical Utility of Fecal Neutrophil Gelatinase-Associated Lipocalin and Calprotectin as Biomarkers of Clostridioides (Clostridium) difficile Infection . Laboratory Medicine Online 10:2, pages 125.
Crossref
Xin Zhang, Shubhagata Das, Sherry Dunbar & Yi-Wei Tang. 2020. 49 85 .
Yao-Wen Cheng & Monika Fischer. (2019) Treatment of Severe and Fulminnant Clostridioides difficile Infection. Current Treatment Options in Gastroenterology 17:4, pages 524-533.
Crossref
J. Hibbard, Z.-D. Jiang & H.L. DuPont. (2019) Fecal calprotectin and fecal indole predict outcome of fecal microbiota transplantation in subjects with recurrent Clostridium difficile infection. Anaerobe 56, pages 102-105.
Crossref
Taojun He, Samuel E. Kaplan, Luz A. Gomez, Xuedong Lu, Lakshmi V. Ramanathan, Mini Kamboj & Yi-Wei Tang. (2018) Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection. European Journal of Clinical Microbiology & Infectious Diseases 37:12, pages 2341-2346.
Crossref
Amoe Baktash, Elisabeth M. Terveer, Romy D. Zwittink, Bastian V. H. Hornung, Jeroen Corver, Ed J. Kuijper & Wiep Klaas Smits. (2018) Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections. Frontiers in Microbiology 9.
Crossref
Anna M. Seekatz & Vincent B. Young. (2016) Modulation of Clostridium difficile infection by dietary zinc. Nature Reviews Gastroenterology & Hepatology 13:12, pages 686-688.
Crossref
Joseph P Zackular, Jessica L Moore, Ashley T Jordan, Lillian J Juttukonda, Michael J Noto, Maribeth R Nicholson, Jonathan D Crews, Matthew W Semler, Yaofang Zhang, Lorraine B Ware, M Kay Washington, Walter J Chazin, Richard M Caprioli & Eric P Skaar. (2016) Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection. Nature Medicine 22:11, pages 1330-1334.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.